Conquer Cancer’s EveryGrant announces Quality Improvement grants, funded by Pfizer, to leverage technology to improve biomarker-driven testing and treatment. Congratulations to the recipients! Read the full release: https://bit.ly/4v1FmSK

#EveryGrant #ConquerCancer #ResearchConquersCancer

It takes a special crowd of people dedicated to changing the cancer landscape to run Conquer Cancer. These are just a few of the determined people who help make sure your gifts advance progress in oncology. 🧡

#ConquerCancer #ResearchConquersCancer #CancerResearch

Your support in 2025 went a long way in protecting progress in oncology for people with cancer everywhere. We can't wait to see what you'll help accomplish in 2026! Read the full report: https://bit.ly/47RMjw3

#ImpactReport #ResearchConquersCancer #ConquerCancer

For centuries, the story of cancer was one of limited options, but today, we are rewriting that narrative. Read our overview of what cancer is, why it’s so hard to treat, and how research transforms our understanding of it. https://bit.ly/4qWeMra

#CancerResearch #ResearchConquersCancer

New Funding opportunity! Applications are OPEN for the @lobularbca.bsky.social Early Investigator Invasive Lobular Carcinoma (ILC) Research Grant. Support for early-stage investigators to build a career in #ILC research. Apply by March 30, 2026! https://bit.ly/4tA0AX7

#ResearchConquersCancer

Nearly half of all soft tissue sarcoma patients experience a recurrence, but Dr. Abdulazeez Salawu's research offers hope. He found that ctDNA can signal recurrence weeks before it shows up on scans. Read more: www.conquer.org/impact/accel...

#RareCancer #ResearchConquersCancer